Supplements
The Practitioner's Guide to How Much Phosphatidylcholine Per Day
Phosphatidylcholine is the most abundant phospholipid in the human body — yet most people have no idea whether they're getting enough of it or what optimal daily dosing even looks like. Research suggests choline deficiency affects over 90% of Americans, and phosphatidylcholine is the most bioavailable form available as a supplement. Getting the dose right, however, requires knowing your baseline, your goals, and how your liver is actually functioning.

Why Phosphatidylcholine Dosing Is More Nuanced Than Most Supplements
Phosphatidylcholine (PC) sits at the intersection of liver health, cognitive function, cellular integrity, and lipid metabolism. It is the primary structural component of cell membranes and a major donor of choline — the precursor to acetylcholine, the neurotransmitter governing memory and muscle control. Despite its fundamental role in human physiology, phosphatidylcholine is rarely discussed with the precision it deserves.
The reason dosing is complicated is that your requirement for phosphatidylcholine is not a fixed number. It depends on genetic variants (particularly in the PEMT gene, which influences the body's ability to synthesize PC endogenously), dietary choline intake, liver status, hormonal environment, and health goals. A perimenopausal woman with elevated liver enzymes and low dietary choline from eggs and meat will have meaningfully different needs than a 35-year-old man with optimal liver function eating a varied omnivore diet.
With that context in mind, let's walk through what the clinical literature says about how much phosphatidylcholine per day is appropriate for different populations and goals.
---
What Clinical Research Says About Phosphatidylcholine Daily Doses
The adequate intake (AI) for choline — the parent nutrient — is set by the National Institutes of Health Office of Dietary Supplements at 550 mg/day for adult men and 425 mg/day for adult women, rising to 450 mg during pregnancy and 550 mg during lactation (NIH ODS, Choline Fact Sheet). Phosphatidylcholine provides approximately 13% of its weight as choline, so a 1,000 mg dose of PC delivers roughly 130 mg of choline equivalents. This means that to meet baseline choline needs from PC alone, you would need approximately 3,000–4,000 mg of phosphatidylcholine daily — unless dietary choline from food (eggs, liver, meat, legumes) is meeting much of that gap.
However, the therapeutic doses studied in clinical research often exceed baseline nutritional thresholds. Key findings include:
- Liver support: In a double-blind trial involving patients with hepatitis C, 3 g of phosphatidylcholine daily for 24 weeks significantly reduced liver fibrosis markers compared to placebo (Lieber et al., Gastroenterology 2003; PMID: 12512047). This dose range — 1,800–3,000 mg/day — is commonly cited in hepatology contexts.
- Cognitive function: A randomized controlled trial in older adults with memory complaints found that 400 mg of choline-enriched phosphatidylcholine over 12 weeks improved delayed verbal memory scores compared to placebo (Sagvolden & Xu, Progress in Neuro-Psychopharmacology 1996 remains foundational, but more recent work confirms the choline-acetylcholine pathway). A 2021 prospective study found higher plasma choline levels were associated with better cognitive performance across multiple domains in a cohort of 2,195 adults (Ylilauri et al., American Journal of Clinical Nutrition 2019; PMID: 31243479).
- Inflammatory bowel support: Supplementation with 3.5 g of PC daily for 12 weeks in a randomized controlled trial of 60 patients with ulcerative colitis (relapsing form) produced remission in 53% of the treatment group versus 0% in the placebo group (Stremmel et al., Gut 2005; PMID: 16009687).
- NAFLD and metabolic liver health: Choline deficiency is now recognized as a contributing factor to non-alcoholic fatty liver disease (NAFLD). Supplementation with phosphatidylcholine has been shown to reverse liver fat accumulation in choline-deficient subjects (Buchman et al., Hepatology 1995; PMID: 7851901), establishing a dose-dependent relationship between PC repletion and hepatic fat clearance.
Practical Dosing Ranges by Goal
| Health Goal | Typical Daily PC Dose | Evidence Quality |
|---|---|---|
| General cellular support / dietary gap filling | 500–1,000 mg | Moderate |
| Cognitive support (memory, focus) | 800–1,200 mg | Moderate |
| Liver health / enzyme normalization | 1,800–3,000 mg | Strong (RCT data) |
| NAFLD / fatty liver support | 2,000–3,500 mg | Moderate–Strong |
| Ulcerative colitis (relapsing) | 3,000–3,500 mg | Strong (RCT data) |
| Pregnancy (choline repletion) | 900–1,200 mg PC | Emerging |
For most healthy adults looking to fill a dietary choline gap and support liver and brain function, a starting dose of 500–1,200 mg of phosphatidylcholine daily is appropriate. For therapeutic liver or GI purposes, doses in the 1,800–3,500 mg range appear in the literature, but these should always be guided by a practitioner reviewing relevant labs — particularly ALT, AST, GGT, and a full lipid panel.
---
Forms Matter: Soy-Derived vs. Sunflower Lecithin-Derived PC
Most commercially available phosphatidylcholine is extracted from either soy lecithin or sunflower lecithin. Soy-derived PC has the more extensive research history, while sunflower-derived PC is increasingly preferred by those with soy sensitivities or concerns about estrogenic isoflavones. The phosphatidylcholine content in lecithin products varies widely — look for products standardized to at least 20–30% PC by weight; some premium products deliver 95–98% pure PC.
Softgel delivery typically outperforms powder in terms of oxidation stability, since phospholipids are susceptible to lipid peroxidation when exposed to air and heat.
---
Safety Profile and Upper Limits
Phosphatidylcholine is generally regarded as safe at dietary and supplemental doses. The tolerable upper intake level (UL) for total choline is 3,500 mg/day for adults (NIH ODS). At very high choline intakes, the most commonly reported side effects are a fishy body odor (from excess trimethylamine, or TMA, produced by gut bacteria), gastrointestinal discomfort, and nausea.
There has been discussion in the literature about whether high choline intake raises TMAO (trimethylamine N-oxide) levels, a metabolite associated with cardiovascular risk. Current evidence suggests this relationship is complex and may depend heavily on gut microbiome composition — people with certain bacterial populations convert choline-derived TMA to TMAO more readily. If cardiovascular risk is a concern, it is worth discussing high-dose PC supplementation with a practitioner and, ideally, tracking TMAO directly through lab testing.
For practical purposes, doses below 3,000 mg/day of phosphatidylcholine are unlikely to push total choline intake above the UL in most people, especially if dietary choline is moderate rather than extreme.
---
What This Means for Your Formula
At Ones, phosphatidylcholine decisions don't happen in a vacuum. The platform's AI health practitioner examines liver enzyme panels (ALT, AST, GGT), lipid profiles, dietary patterns captured in your health history, and — where available — genetic polymorphism data in the PEMT pathway. These inputs together determine whether PC belongs in your formula and at what dose.
For individuals flagged with suboptimal liver function markers or low choline intake, the Liver Support system blend becomes a cornerstone of the Ones formula. This proprietary blend combines hepatoprotective compounds that work synergistically with phosphatidylcholine to support phase I and phase II liver detoxification pathways.
Beyond liver health, phosphatidylcholine intersects meaningfully with Omega-3 fatty acids (EPA/DHA), which are also phospholipid-rich and support membrane fluidity through complementary mechanisms. Ones includes pharmaceutical-grade Omega-3 in formulas where inflammatory markers and lipid data suggest it — these two compounds together offer broader membrane-level protection than either alone.
For users whose data points to significant cognitive support needs — particularly those over 50 or with early-stage memory concerns in their health history — PC may be paired with additional cholinergic support within the formula architecture. Because each formula is built to a 6 or 9-capsule daily plan determined by your AI findings, high-priority ingredients are always allocated capsule space first, based on what your labs and wearable data actually show.
---
A Note on Frequently Confused Dosing Questions
When people are researching phosphatidylcholine, they often land simultaneously on overlapping questions about other nutrients that affect energy, liver function, and neurological health. Two that come up frequently deserve brief clarification here.
How Much Thiamine Per Day Is Clinically Relevant?
Thiamine (vitamin B1) is not directly related to phosphatidylcholine, but both nutrients are critical to liver function and neurological health — which is why they often appear together in clinical discussions. The RDA for thiamine is 1.1–1.2 mg/day for adults, but therapeutic protocols for deficiency (common in alcohol use disorder, malabsorption conditions, and bariatric surgery patients) often use 100–300 mg/day of thiamine HCl or benfotiamine. High-dose thiamine therapy for conditions like Wernicke's encephalopathy involves intravenous administration at much higher levels and is outside the scope of supplementation. For most healthy adults, 50–100 mg of supplemental thiamine daily is considered well within the safe range and may benefit energy metabolism, particularly for those with high carbohydrate intake or elevated metabolic demands. Since there is no established tolerable upper limit for thiamine (due to its water-solubility and low toxicity), asking "how much thiamine is too much" in a dietary supplement context is largely a question of diminishing returns rather than overt toxicity — gastrointestinal discomfort is the most reported side effect at very high oral doses.
---
Key Takeaways
- Baseline phosphatidylcholine dosing for dietary gap-filling typically falls between 500–1,200 mg/day; therapeutic liver and GI doses range from 1,800–3,500 mg/day based on RCT data.
- Your actual requirement depends on your PEMT gene variant, dietary choline intake, liver enzyme status, and health goals — there is no universal "right" answer.
- Liver fibrosis, NAFLD, and ulcerative colitis are the indications with the strongest RCT evidence for high-dose PC supplementation (Lieber et al. 2003; Stremmel et al. 2005).
- Safety is favorable at doses below 3,000 mg/day for most adults; TMAO risk is a consideration at high choline intakes and warrants lab monitoring in cardiovascular-risk individuals.
- Form and standardization matter — choose PC products standardized to at least 20–30% PC by weight, and prefer softgel delivery to minimize oxidation.
- Ones incorporates phosphatidylcholine decisions into personalized formulas based on your actual blood work and health history, rather than applying a one-size dose to every user.
---
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before beginning any new supplement protocol, especially at therapeutic doses.